Annual SG&A
$24.25 M
-$805.00 K-3.21%
31 December 2023
Summary:
PMV Pharmaceuticals annual selling, general & administrative expenses is currently $24.25 million, with the most recent change of -$805.00 thousand (-3.21%) on 31 December 2023. During the last 3 years, it has risen by +$13.24 million (+120.25%). PMVP annual SG&A is now -3.21% below its all-time high of $25.05 million, reached on 31 December 2022.PMVP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.94 M
-$601.00 K-10.84%
30 September 2024
Summary:
PMV Pharmaceuticals quarterly selling, general & administrative expenses is currently $4.94 million, with the most recent change of -$601.00 thousand (-10.84%) on 30 September 2024. Over the past year, it has dropped by -$1.10 million (-18.22%). PMVP quarterly SG&A is now -27.16% below its all-time high of $6.78 million, reached on 31 March 2022.PMVP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.31 B
-$51.47 M-4.10%
30 September 2024
Summary:
PMV Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.31 billion, with the most recent change of -$51.47 million (-4.10%) on 30 September 2024. Over the past year, it has dropped by -$1.33 billion (-5358.29%). PMVP TTM SG&A is now -1633.13% below its all-time high of $25.45 million, reached on 30 June 2022.PMVP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMVP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.2% | -18.2% | -5358.3% |
| 3 y3 years | +120.3% | -16.8% | -6698.4% |
| 5 y5 years | +381.2% | +219.8% | -10000.0% |
PMVP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.2% | +120.3% | -27.2% | at low | -153.8% | at low |
| 5 y | 5 years | -3.2% | +381.2% | -27.2% | +219.8% | -1633.1% | at low |
| alltime | all time | -3.2% | +121.4% | -27.2% | +219.8% | -1633.1% | at low |
PMV Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.94 M(-10.8%) | $21.04 M(-5.0%) |
| June 2024 | - | $5.54 M(+10.1%) | $22.14 M(-3.2%) |
| Mar 2024 | - | $5.04 M(-8.8%) | $22.88 M(-5.7%) |
| Dec 2023 | $24.25 M(-3.2%) | $5.52 M(-8.6%) | $24.25 M(-2.5%) |
| Sept 2023 | - | $6.04 M(-3.8%) | $24.86 M(+1.4%) |
| June 2023 | - | $6.28 M(-2.0%) | $24.53 M(-0.6%) |
| Mar 2023 | - | $6.41 M(+4.4%) | $24.68 M(-1.5%) |
| Dec 2022 | $25.05 M(+14.9%) | $6.14 M(+7.5%) | $25.05 M(-0.7%) |
| Sept 2022 | - | $5.71 M(-11.1%) | $25.22 M(-0.9%) |
| June 2022 | - | $6.42 M(-5.3%) | $25.45 M(+4.2%) |
| Mar 2022 | - | $6.78 M(+7.6%) | $24.41 M(+12.0%) |
| Dec 2021 | $21.80 M | $6.30 M(+6.2%) | $21.80 M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $5.93 M(+10.2%) | $19.82 M(+19.4%) |
| June 2021 | - | $5.39 M(+29.0%) | $16.59 M(+23.0%) |
| Mar 2021 | - | $4.17 M(-3.4%) | $13.48 M(+22.5%) |
| Dec 2020 | $11.01 M(+87.3%) | $4.32 M(+59.5%) | $11.01 M(+31.9%) |
| Sept 2020 | - | $2.71 M(+18.8%) | $8.35 M(+16.2%) |
| June 2020 | - | $2.28 M(+34.3%) | $7.18 M(+46.6%) |
| Mar 2020 | - | $1.70 M(+2.6%) | $4.90 M(+53.1%) |
| Dec 2019 | $5.88 M(+16.7%) | $1.66 M(+7.2%) | $3.20 M(+107.2%) |
| Sept 2019 | - | $1.54 M | $1.54 M |
| Dec 2018 | $5.04 M(-108.3%) | - | - |
| Dec 2012 | -$60.65 M(+76.5%) | - | - |
| Dec 2011 | -$34.36 M(-69.6%) | - | - |
| Dec 2008 | -$113.16 M | - | - |
FAQ
- What is PMV Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual SG&A year-on-year change?
- What is PMV Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly SG&A year-on-year change?
- What is PMV Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals TTM SG&A year-on-year change?
What is PMV Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of PMVP is $24.25 M
What is the all time high annual SG&A for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual selling, general & administrative expenses is $25.05 M
What is PMV Pharmaceuticals annual SG&A year-on-year change?
Over the past year, PMVP annual selling, general & administrative expenses has changed by -$805.00 K (-3.21%)
What is PMV Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of PMVP is $4.94 M
What is the all time high quarterly SG&A for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $6.78 M
What is PMV Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, PMVP quarterly selling, general & administrative expenses has changed by -$1.10 M (-18.22%)
What is PMV Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of PMVP is -$1.31 B
What is the all time high TTM SG&A for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high TTM selling, general & administrative expenses is $25.45 M
What is PMV Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, PMVP TTM selling, general & administrative expenses has changed by -$1.33 B (-5358.29%)